<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04905134</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00102912</org_study_id>
    <secondary_id>1R01DE028555-01A1</secondary_id>
    <nct_id>NCT04905134</nct_id>
  </id_info>
  <brief_title>Low-Cost, Portable Flexible Nasopharyngoscope in Head &amp; Neck Cancers in Low Resource Settings</brief_title>
  <official_title>Partnership to Establish a Practice Based Network to Assess for Head and Neck Cancers Using a Low-Cost Portable Flexible Nasopharyngoscope</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Dental and Craniofacial Research (NIDCR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to develop and evaluate a low-cost, portable, flexible nasopharyngeal scope&#xD;
      (FNS) used to assess head and neck cancers (HNC) in low resource settings. The FNS will be&#xD;
      compared to the rigid endoscope that is used as standard of care in terms of ease of use,&#xD;
      image quality, and perceived pain. The ultimate goal is to implement widespread training and&#xD;
      use of the optimized FNS to improve care capacity by local heath providers in Vietnam through&#xD;
      timely diagnosis, treatment and/or appropriate specialized referral for HNC patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of providers who who reported the FNS is easy to use</measure>
    <time_frame>up to 15 minutes</time_frame>
    <description>Measured using a 5 point scale, with 1 = very easy, 2=easier, 3 = same, 4= harder and 5 = very hard</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of image quality of rigid scope</measure>
    <time_frame>Day 1</time_frame>
    <description>Measured using 5 point scale, with 1 being poor and 5 being excellent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of image quality of flexible scope</measure>
    <time_frame>Day 1</time_frame>
    <description>Measured using 5 point scale, with 1 being poor and 5 being excellent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients who reported perceived pain following use of the flexible scope</measure>
    <time_frame>Day 1</time_frame>
    <description>Comparison using a 3 point scale, with 1 being much less and 3 being much more</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients who experienced an adverse event following the use of the flexible scope</measure>
    <time_frame>Day 1</time_frame>
    <description>measured by a provider questionnaire following completion of flexible scope exam</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Head and Neck Cancer</condition>
  <condition>Oral Cancer</condition>
  <arm_group>
    <arm_group_label>Patients evaluated using flexible nasopharyngoscope prototype</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients evaluated using rigid nasopharyngoscope per SOC</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Providers using flexible nasopharyngoscope prototype</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasopharyngoscope</intervention_name>
    <description>Low-cost, flexible scope prototype will compared to rigid scope used as standard of care.</description>
    <arm_group_label>Patients evaluated using flexible nasopharyngoscope prototype</arm_group_label>
    <arm_group_label>Providers using flexible nasopharyngoscope prototype</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Provide signed and dated informed consent form&#xD;
&#xD;
          -  Willing to comply with all study procedures and be available for the duration of the&#xD;
             study&#xD;
&#xD;
          -  Male or female, aged 18 or older&#xD;
&#xD;
          -  Patients who clinical meet clinical criteria for rigid scope examination of the upper&#xD;
             aerodigestive tract. This includes signs and symptoms such as dysphagia, nasal&#xD;
             obstruction, neck mass, throat pain, and hoarseness.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects who have complications from the SOC rigid exam&#xD;
&#xD;
          -  Anything that would place the individual at increased risk or preclude the&#xD;
             individual's full compliance with or completion of the study.&#xD;
&#xD;
          -  Withdrawal of consent during the study duration&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Walter Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Walter Lee, MD</last_name>
    <phone>919-681-8449</phone>
    <email>walter.lee@duke.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amy Walker</last_name>
    <phone>919-684-1732</phone>
    <email>amy.walker1@duke.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National ENT Hospital</name>
      <address>
        <city>Hanoi</city>
        <country>Vietnam</country>
      </address>
    </facility>
    <contact>
      <last_name>Trung Nguyen, MD</last_name>
      <phone>84 24 3852 3798</phone>
      <email>trungent23@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Trung Nguyen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Vietnam</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 24, 2021</study_first_submitted>
  <study_first_submitted_qc>May 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 27, 2021</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
    <mesh_term>Mouth Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

